New Treatment for Multiple Sclerosis Shows Promise in Lab Tests
Sign UpThis is a 5 minute preview of a 1 minute video
Install Web Player Beta to watch the full video in your browser or download it to your PCYou're watching a full 1 minute video using the Veoh Web Player
To download the original quality video, select the Download Options link below- By:
- Brandwidth
- Description
- Lab tests of Bowman-Birk inhibitor (BBI), a soy-derived protease inhibitor, show promise in the treatment of Multiple Sclerosis.
- Language:
- English
Would you like to comment?
Sign Up Now for a free account or Log In.